Global Efficacy Testing Market - 2023-2030

Global Efficacy Testing Market - 2023-2030

Global Efficacy Testing Market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing with a CAGR of XX % during the forecast period 2023-2030.

An efficacy test ensures that the packaging and marketing of a product accurately reflect the intended use of any statement of the product. It investigates the benefits or harms a product may cause when used on or by humans. Various efficacy tests can be performed, depending on the product, and assays can be tailor-made to determine whether the product meets particular criteria. The results of a successful test can be used to give evidence of the efficacy of a product to the relevant authority.

Market Dynamics: Drivers and Restraints

Rise in outsourcing of research and development by the pharmaceutical sector

Outsourcing enables pharmaceutical companies to cut both their operating and production expenses, reducing financial risk. As a result, pharmaceutical corporations are increasingly outsourcing R&D operations to private contract research organisations (CROs) as a research and development strategy.

For instance, in September 2022, Emyria Limited, a clinical-stage biotechnology company collaborated with PsychoGenics, a neuroscience preclinical drug discovery and contract research organization (CRO). Under this collaboration, Emyria uses PsychoGenic's drug discovery platform, SmartCube, which is a next-generation automated testing platform. Such instances are expected to increase the demand for efficacy testing products, and hence, it is anticipated to contribute to market growth over the forecast period.

Furthermore, the global efficacy testing market is also driven by various other factors like, rise in consumer health concerns, an increase in cosmetic products and others which help the market to grow during the forecast period.

Market Dynamics: Restraint

The efficacy testing market is hampered by various factors some of which are adverse effects of chemical disinfectants, Most of the chemical disinfectants currently available in the market have toxic properties. Also, other factors like high investment of time and capital in the testing procedures, regulatory hurdles and others will also hamper the market growth during the forecast period.

Segment Analysis

The global efficacy testing market is segmented based on service type, application, end-user and region.

The disinfectant efficacy testing segment from the service type segment accounted for approximately 54.2% of the efficacy testing market share

The disinfectant efficacy testing segment from the service type segment accounted for approximately 54.2% and is expected to be dominated during the forecast period. Disinfectant efficacy testing is the determination of the biocidal effect of a disinfectant in the environment which is used, against the organisms it is intended for use against.

For instance, in October 2023, STEMart, a US-based provider of comprehensive services for all phases of medical device development, stated the launch of its Disinfection Efficacy Studies Services in various standards to ensure the safety of medical devices. The services can be performed to evaluate the effectiveness of disinfectants against a wide range of microorganisms, including bacteria, yeast, viruses, and fungi.

Geographical Analysis

North America accounted for approximately 39.4% of the market share in 2022

North America is estimated to hold about 39.4% of the total market share throughout the forecast period, owing to the factors like, a rise in clinical trials, increasing R&D and adoption of the quality by design (QbD) approach among the market players in the region, which are predicted to drive market growth.

For instance, in May 2022, the Pfizer-BioNTech COVID-19 vaccine demonstrated a strong immune response, high efficacy, and favourable safety in children 6 months to under 5 years following the third dose. Vaccine efficacy of 80.3% was observed in the descriptive analysis of three doses when Omicron was the predominant variant.

Moreover, in November 2020, Pfizer Inc. and BioNTech SE announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2, has demonstrated evidence of efficacy against COVID-19 in participants without prior evidence of SARS-CoV-2 infection, based on the first interim efficacy analysis conducted on November 8, 2020, by an external, independent Data Monitoring Committee (DMC) from the Phase 3 clinical study.

COVID-19 Impact Analysis

The COVID-19 pandemic altered people's perceptions of cleanliness, resulting in an urgent demand for disinfection goods that soon emptied their supply, accelerating the industry's expansion. Furthermore, in response to the EPA adding numerous natural disinfectants to its approved list for combating COVID-19, governmental organisations announced special financial aid for the development of preventive and curative drugs, the purchase of critical care medical devices, and the expedited approval of diagnostic tests.

Market Segmentation

By Service Type
• Disinfectant Efficacy Testing
Surface Test Method
Suspension Test Method
• Antimicrobial Efficacy Testing
Traditional Test Method
Rapid Test Method

By Application
• Pharmaceutical Manufacturing
• Cosmetics and Personal Care Products
• Consumer Product
• Medical Devices
• Others

By End User
• Pharmaceutical & Biotechnology Companies
• Research Institutes
• Others

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
UK
France
Italy
Spain
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape

The major global players in the market include Abbott Analytical, Accugen Laboratories, Inc., Almac Group, ALS Limited, Bioscience Laboratories, Inc., Blutest Laboratories Limited, Charles River Laboratories International, Inc., Consumer Product Testing Company (CPTC), Eurofins Scientific, Lucideon among others.

Key Developments

 In June 2022, Eurofins Cosmetics & Personal Care acquired a majority stake in CRA Korea Inc., a South Korea-based clinical testing laboratory primarily focused on providing safety and efficacy studies, consumer tests, and sensory evaluation to the cosmetics and personal care industry.

 In April 2022, MSL Solution Providers introduced efficacy testing of UV devices. The new method standardises the distance of UV emitters from test surfaces, allowing for power versus contact time assessment. It covers UV device efficacy testing, determining bactericidal, mycobactericidal, sporicidal, yeasticidal, fungicidal, virucidal, and phagocidal activities, based on existing EN 17272:2020 standards.

 In May 2020, Diversey, Inc., a global leader in healthcare and infection prevention products and solutions, stated it would test several of its disinfectant products for efficacy against SARS-CoV-2, which causes COVID-19. These results will be submitted to the EPA for approval.

Why Purchase the Report?
• To visualize the global efficacy testing market segmentation based on service type, application, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analysing trends and co-development.
• Excel data sheet with numerous data points of efficacy testing market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global efficacy testing market report would provide approximately 77 tables, 79 figures and 187 Pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies